Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial.

Russell L RothmanThomas G StewartAhmad MouradDavid R BoulwareMatthew W McCarthyFlorence ThicklinIdania T Garcia Del SolJose Luis GarciaCarolyn T BramanteNirav S ShahUpinder SinghJohn C WilliamsonPaulina A RebolledoPrasanna JagannathanTiffany Schwasinger-SchmidtAdit A GindeMario CastroDushyantha JayaweeraMark SulkowskiNina GentileKathleen McTigueG Michael FelkerAllison DeLongRhonda WilderSean CollinsSarah E DunsmoreStacey J AdamGeorge J HannaElizabeth ShenkmanAdrian F HernandezSusanna NaggieChristopher J Lindsellnull null

Published in: medRxiv : the preprint server for health sciences (2024)

ClinicalTrials.gov ( NCT04885530 ).

Keyphrases

coronavirus disease
double blind
sars cov
placebo controlled
phase iii
clinical trial
respiratory syndrome coronavirus